Masjedi Moein, Solhjoo Aida
Department of Pharmaceutics, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
Daroosazan Sorena Exir Pharmaceutical Company, Shiraz, Iran.
J Cosmet Dermatol. 2022 Dec;21(12):7178-7193. doi: 10.1111/jocd.15453. Epub 2022 Dec 12.
This study aimed to perform molecular docking studies to identify possibilities of the inhibitory potential of the trigonelline present in fenugreek seeds on the human tyrosinase, standardize fenugreek extract, formulate, and characterize an emulgel-containing fenugreek extract-entrapped niosomal vesicles.
The docking study was performed using AutoDock software. The extract was standardized by the RP-HPLC method. Emulgels containing fenugreek extract and fenugreek extract-entrapped niosomes were optimized by the D-optimal method. In vitro characterization and stability studies were also carried out.
The lowest energy docked poses of trigonelline on the human tyrosinase complex was calculated -5.8 kcal/mol. Also, in vitro assessment of the tyrosinase inhibitory effect of trigonelline and comparison of IC50 values of trigonelline and kojic acid revealed that the enzyme inhibition efficacy of trigonelline was stronger than that of kojic acid. Optimization led to emulgels with desired viscosity, droplet size, and spreadability values. The release study showed that trigonelline was released from the niosomes at a lower rate compared with extract containing emulgel. Permeation investigations revealed that trigonelline in niosomes has a higher ability to permeate through the skin.
In conclusion, in silico and in vitro studies have shown that trigonelline can be assumed as an appropriate candidate for developing new cosmetic preparations and nonionic surfactant vesicles help trigonelline to permeate through the skin to a higher extent. However, clinical trials should be performed to confirm these findings.
本研究旨在进行分子对接研究,以确定胡芦巴种子中所含的葫芦巴碱对人酪氨酸酶的抑制潜力,对胡芦巴提取物进行标准化,制备并表征含胡芦巴提取物的纳米脂质体囊泡的乳胶凝胶。
使用AutoDock软件进行对接研究。采用反相高效液相色谱法对提取物进行标准化。通过D-最优法优化含胡芦巴提取物和包裹胡芦巴提取物的纳米脂质体的乳胶凝胶。还进行了体外表征和稳定性研究。
计算出葫芦巴碱与人酪氨酸酶复合物对接构象的最低能量为-5.8千卡/摩尔。此外,对葫芦巴碱的酪氨酸酶抑制作用进行体外评估,并比较葫芦巴碱和曲酸的半数抑制浓度(IC50)值,结果表明葫芦巴碱的酶抑制效果强于曲酸。优化后得到了具有所需粘度、液滴大小和铺展性值的乳胶凝胶。释放研究表明,与含提取物的乳胶凝胶相比,葫芦巴碱从纳米脂质体中的释放速率较低。渗透研究表明,纳米脂质体中的葫芦巴碱具有更高的透皮能力。
总之,计算机模拟和体外研究表明,葫芦巴碱可被认为是开发新型化妆品制剂的合适候选物,非离子表面活性剂囊泡有助于葫芦巴碱更好地渗透皮肤。然而,需要进行临床试验来证实这些发现。